Gene ID 142980
Formulation 50 µg (0.5 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 50% glycerol, 1% BSA and 0.02% thimerosal.
Antibody Target TLR3
Shipping gel pack
Concentration 0.5 mg/ml
Storage Temp. -20 °C
Appearance Colorless liquid
Research Use For Rersearch Use Only! Not to be used in humans.
Shelf Life 1 year
Handling The peptide solution should be gently mixed before use.
Test You can block the antibody by the specific target amino acid sequence of peptide.
Properties blocking peptide
Description Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
Short name TLR3 Blocking Peptide
Technique blocking peptide, Blocking, peptide
Alternative name toll-like receptor 3 inhibiting short protein sequence
Alternative technique control
Alternative to gene target toll-like receptor 3, CD283 and IIAE2, TLR3 and IDBG-47294 and ENSG00000164342 and 7098, protein binding, Cell surfaces, Tlr3 and IDBG-152685 and ENSMUSG00000031639 and 142980, TLR3 and IDBG-628571 and ENSBTAG00000008682 and 281535